Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 6
2003 10
2004 8
2005 16
2006 17
2007 14
2008 12
2009 12
2010 12
2011 17
2012 9
2013 12
2014 17
2015 19
2016 17
2017 17
2018 10
2019 16
2020 13
2021 20
2022 11
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Marando A, Zagni M, Negrelli M, Valtorta E, Lauricella C, Motta V, Veronese S, Cerea G, Giannetta LG, Ciarlo G, Signorelli D, Pizzutilo EG, Bonoldi E, Pelosi G. Marando A, et al. Among authors: pelosi g. Pathologica. 2024 Feb;116(1):13-21. doi: 10.32074/1591-951X-957. Pathologica. 2024. PMID: 38482671 Free PMC article. Review.
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G, Melocchi V, Dama E, Hofman P, De Luca M, Albini A, Gemelli M, Ricotta R, Papotti M, La Rosa S, Uccella S, Harari S, Sonzogni A, Asiedu MK, Wigle DA, Bianchi F. Pelosi G, et al. Exp Mol Pathol. 2024 Feb;135:104882. doi: 10.1016/j.yexmp.2024.104882. Epub 2024 Jan 20. Exp Mol Pathol. 2024. PMID: 38237798 Free article.
Immune-related gigantomastia: a case study.
Lozito A, Gemelli M, Micello D, Vinci V, Pelosi G, Ricotta R. Lozito A, et al. Among authors: pelosi g. Immunotherapy. 2023 Sep;15(13):1001-1007. doi: 10.2217/imt-2023-0056. Epub 2023 Jul 11. Immunotherapy. 2023. PMID: 37431623
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation.
Scagliotti A, Capizzi L, Cazzaniga ME, Ilari A, De Giorgi M, Cordani N, Gallazzi M, Bruno A, Pelosi G, Albini A, Lavitrano M, Grassilli E, Cerrito MG. Scagliotti A, et al. Among authors: pelosi g. Front Oncol. 2022 Nov 30;12:998274. doi: 10.3389/fonc.2022.998274. eCollection 2022. Front Oncol. 2022. PMID: 36531071 Free PMC article.
Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee.
Thunnissen E, Beasley MB, Borczuk A, Dacic S, Kerr KM, Lissenberg-Witte B, Minami Y, Nicholson AG, Noguchi M, Sholl L, Tsao MS, Le Quesne J, Roden AC, Chung JH, Yoshida A, Moreira AL, Lantuejoul S, Pelosi G, Poleri C, Hwang D, Jain D, Travis WD, Brambilla E, Chen G, Botling J, Bubendorf L, Mino-Kenudson M, Motoi N, Chou TY, Papotti M, Yatabe Y, Cooper W; Invasion Working Group. Thunnissen E, et al. Among authors: pelosi g. J Thorac Oncol. 2023 Apr;18(4):447-462. doi: 10.1016/j.jtho.2022.11.026. Epub 2022 Dec 9. J Thorac Oncol. 2023. PMID: 36503176 Free article.
260 results